Cargando…
Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis
Autores principales: | Kazory, Amir, Racusen, Lorraine C., Berliner, Adam R., Gimenez, Luis F., Jaar, Bernard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477861/ https://www.ncbi.nlm.nih.gov/pubmed/28656986 http://dx.doi.org/10.1093/ndtplus/sfn102 |
Ejemplares similares
-
Idiopathic membranoproliferative glomerulonephritis treated with mycophenolate mofetil
por: Koratala, Abhilash, et al.
Publicado: (2018) -
Chapter 8: Idiopathic membranoproliferative glomerulonephritis
Publicado: (2012) -
Membranoproliferative glomerulonephritis
por: Alchi, Bassam, et al.
Publicado: (2009) -
Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis
por: Ostalska-Nowicka, Danuta, et al.
Publicado: (2011) -
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
por: Nikolopoulou, Aikaterini, et al.
Publicado: (2019)